Clinical trials recruiting for Brain Tumor
13
Recruiting trials
18
US states with sites
19
Countries
15%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| 18F-DOPA | 1 |
| 18F-FDG | 1 |
| 68Ga-RGD | 1 |
| 68Ga-RM26 | 1 |
| 68Ga-RM26-RGD | 1 |
| AGuIX gadolinium-based nanoparticles | 1 |
| APL-101 Oral Capsules | 1 |
| Abemaciclib | 1 |
| Atezolizumab | 1 |
| Brodalumab | 1 |
| Cemiplimab | 1 |
| Furosemide Injection | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Arizona | 3 |
| California | 3 |
| Florida | 3 |
| Massachusetts | 3 |
| New York | 3 |
| Texas | 3 |
| North Carolina | 2 |
| Pennsylvania | 2 |
| Virginia | 2 |
| Wisconsin | 2 |
| District of Columbia | 1 |
| Illinois | 1 |
Top cities
Boston, Massachusetts 3Houston, Texas 3Los Angeles, California 2New York, New York 2Phoenix, Arizona 2Tampa, Florida 2Baltimore, Maryland 1Brooklyn, New York 1Chapel Hill, North Carolina 1Chicago, Illinois 1
Self-screener
Recruiting trials
- 18F-DOPA II - PET Imaging Optimization
- 68Ga-RM26-RGD PET/CT Imaging in the GRPR and αvβ3 Positive Tumor Patients
- APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets
- Brodalumab in the Treatment of Immune-Related Adverse Events
- Determining Postoperative Recovery and the Impact of Adverse Events in Neurosurgery Based on Self-reported, App-based Longitudinal Assessment
- Engineered TILs/CAR-TILs to Treat Advanced Solid Tumors
- Mapping of Human Cognition
- Remote Neuropsychological Assessment of Patients With Neurological Disorders and Injuries
- Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases
- The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
- Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders
Related conditions
Trials recruiting for Brain Tumor often also study these conditions. Each links to its own recruiting-trial list.
Lung cancer 2180Breast cancer 2239Pancreatic cancer 870Colorectal cancer 1359Prostate cancer 1234Liver cancer 43Epilepsy 350Thyroid Cancer 21Rectal cancer 152Parkinson's disease 522
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Brain Tumor trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.